Cartesian Therapeutics logo
VerifiedBiotechnology Research· Founded 2016

Cartesian Therapeutics

Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis with plans to initiate a Phase 2 trial in myositis. For more information, please visit

7-day free trial · no credit card

HeadquartersFrederick, United StatesEmployees90(51 to 200)Founded year2016Websitecartesiantherapeutics.comLinkedIn profileLinkedIn

Verified contacts

83

available on Kipplo

LinkedIn employees

90

51 to 200 range

Open roles

—

no listings

Distinct roles

67

indexed titles

Tech stack

1

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 83 verified contacts at Cartesian Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

83 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Cartesian Therapeutics

67 distinct titles indexed · top 10 shown.

  • 3cell therapy specialist
  • 2cell therapy specialist ii
  • 2senior consultant
  • 2senior scientist
  • 1asset lead consultant
  • 1assistant controller
  • 1associate director
  • 1associate director director, bioprocess development, msat, car-t cell therapy
  • 1associate director of clinical operations
  • 1associate director of good clinical practice
  • +57more titles

Sign up to unlock all 83 contacts at Cartesian Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 83 verified contacts at Cartesian Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Cartesian Therapeutics | Kipplo Discover